San Jose – Textile developer Livinguard has launched a new line of knitted garments, which integrate its patented antimicrobial treatment.
It comes after the company concluded third-party tests which demonstrated that the technology can kill bacteria at a >7 log10 rate (99.99999%).
“The COVID-19 pandemic has underscored the importance of hygiene technology in protecting the health of people across the world, and we continue to adapt our Livinguard technology to new consumer products, including shirts with permanent antiviral and bacteria-fighting properties,” said Sanjeev Swamy, Livinguard’s founder and CEO.
Livinguard’s patented non-leaching formula captures and kills odour-causing bacteria, and has proven its efficacy in face masks applications.
The principle underlying the Livinguard Technology is the deactivation of microbes including bacteria and viruses. The technology applies a positive charge at the molecular level to textile surfaces, making them more powerful than the negative charge of microbes. Therefore, microbes are deactivated when they encounter textiles treated with Livinguard technology.
With new consumer-facing applications presenting themselves as the world reopens, the company has chosen to produce apparel that will integrate the solution.
“Over the past year, the world at large has learned what we at Livinguard have always known – we must commit to embracing hygiene innovation in products we use in all aspects of our daily lives, from the clothing we wear and the linens we use, to the carpets we install and the protective products our frontline workers continue to rely on,” said Swamy.
“The recent findings by Hohenstein Labs reaffirms our position as an innovator in the hygiene space. Our bacteria-killing properties can save lives and have a significant impact in real-world applications.”